Clostridium botulinum

Botulism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Botulism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Clostridium botulinum On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Clostridium botulinum All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Clostridium botulinum
CDC on Clostridium botulinum
Clostridium botulinum in the news
Blogs on Clostridium botulinum
Directions to Hospitals Treating Botulism
Risk calculators and risk factors for Clostridium botulinum

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S., Keanu Ngo[2]

Overview

Botulism is caused by botulinum neurotoxin (BoNT), produced by Clostridium botulinum and, less commonly, by neurotoxigenic strains of Clostridium butyricum (typically type E) and Clostridium baratii (typically type F). Disease results from absorption of toxin into the circulation from a gastrointestinal (mucosal) or wound surface. The causative exposure differs by clinical form: ingestion of preformed toxin (foodborne botulism) versus ingestion or wound inoculation of spores that germinate and produce toxin in situ (infant, adult intestinal colonization, and wound botulism). BoNT/A, B, E, and rarely F cause essentially all human disease, with serotypes A and B most prevalent in the United States.

Causative organisms

• Clostridium botulinum — a Gram-positive, spore-forming, obligate anaerobic bacillus that is ubiquitous in soil and aquatic sediment worldwide. It is a heterogeneous species comprising four physiologic groups (I–IV); human disease is caused almost exclusively by Group I (proteolytic; types A, B, F) and Group II (non-proteolytic; types B, E, F). Group III causes animal disease, and Group IV (reclassified C. argentinense, type G) has not been linked to naturally occurring human or animal illness.
• Related neurotoxigenic clostridia — C. butyricum (Group VI) can produce type E toxin and C. baratii (Group V) can produce type F toxin, each causing clinically identical illness, including infant botulism. Type F C. baratii disease can progress rapidly.

The organism itself is non-invasive; all pathology derives from the neurotoxin. Detailed serotype–SNARE biology is covered in Pathophysiology; the group/serotype taxonomy is covered in Classification.

Serotypes causing human disease

Seven classical, immunologically distinct serotypes (BoNT/A–G) are recognized, with more than 40 subtypes; additional molecules (the A/F hybrid "H"/HA/FA and BoNT/X) have been described.

• A, B, E, and rarely F cause human botulism; A and B predominate in the United States.
• Type E is classically associated with fish and other marine/aquatic and high-latitude sources and can grow and produce toxin at refrigeration temperatures (Group II is psychrotrophic).
• Types C and D cause animal disease; type G has not been assigned to a natural human outbreak.

Serotype tends to track the causative source: types A and B predominate in home-canned/preserved vegetables and other terrestrial foods, whereas type E is characteristically linked to fish and aquatic/marine sources.

Conditions permitting toxin production

BoNT is synthesized during late-exponential/stationary-phase growth and released on bacterial cell lysis; its synthesis is co-regulated with sporulation (via the transcription factor Spo0A), and toxin is liberated together with the mature spore on mother-cell lysis. The key clinical point is that spores—the environmentally resistant, dormant form—must first germinate and multiply before neurotoxin appears. Growth and toxin production require a permissive combination of conditions that is rarely met simultaneously, which explains the rarity of disease.

Permissive conditions include:

• Anaerobic environment (e.g., sealed cans/jars, deep wounds, the infant gut lumen).
• Low acidity — pH >4.6; toxin is not formed reliably below pH 4.6, the basis for acidification as a food-safety control. Active growth occurs over approximately pH 4.8–8.5; the pH 4.6 cutoff is the regulatory threshold separating "acid" from "low-acid" foods, and toxin formation below pH 4.6 occurs only under unusual strictly anaerobic, high-protein conditions.
• Low salt and low sugar content, and adequate water activity.
• Permissive temperature — growth occurs roughly between 3°C and 48°C; Group II strains (types B, E, F) can grow at refrigeration temperatures, a concern for minimally processed chilled foods. Non-proteolytic Group II strains have produced toxin at temperatures as low as 3°C in experimental and food-matrix studies, underscoring the risk in minimally processed, vacuum-packed, or sous-vide chilled foods where refrigeration is the primary control.

Heat behavior is central to prevention: the toxin is heat-labile (inactivated at ~80°C for 30 min or 100°C for ~5 min), whereas spores are highly heat-resistant (Group I spores survive prolonged boiling and require the "botulinum cook," 121°C for ~3 min under pressure, as used in low-acid canning).

Causes by clinical form

A mechanistic distinction underlies specimen selection: foodborne botulism involves ingested preformed toxin with no ongoing intestinal production, whereas infant, adult intestinal colonization, and wound botulism involve in situ toxin production, so neurotoxigenic clostridia may be shed in stool for weeks (documented for 41–61 days in adult intestinal colonization).

Foodborne botulism (ingestion of preformed toxin)

Results from eating food in which spores germinated and produced toxin under anaerobic, low-acid conditions. The most common causes in the United States are improperly home-canned/preserved foods and inadequately refrigerated cooked foods; less common sources include commercially processed foods, restaurant-associated foods, fermented fish, and prison-made wine ("pruno").

Infant botulism (intestinal colonization)

Results from ingestion of spores that germinate and colonize the large intestine, producing toxin in situ in infants younger than 12 months. Honey is the only avoidable food source definitively linked to disease, but it accounts for a minority of cases (≈4% in recent US data); most US cases are attributed to ingestion of ubiquitous environmental/airborne dust and soil spores. Rarely implicated foods include powdered infant formula (nonsterile), dry cereals, and herbal teas. Corn syrup has not been proven to cause disease.

Wound botulism

Results from contamination of devitalized tissue with spores that germinate under anaerobic conditions and produce toxin. Most modern cases arise from injection drug use ("skin popping," black-tar heroin; rarely methamphetamine); gross trauma or crush injury is a less common predisposing event. Unlike other forms, fever may be present when the wound is secondarily infected.

Adult intestinal colonization (toxemia) botulism

The adult/older-child analogue of infant botulism, in which ingested spores colonize the gut and produce toxin in situ. It is exceedingly rare and typically requires a predisposing alteration of gut anatomy or flora—prior bowel or gastric surgery, inflammatory bowel disease, or recent antimicrobial exposure.

Non-naturally occurring forms

Iatrogenic botulism follows injection of excess therapeutic/cosmetic BoNT; inhalational botulism does not occur naturally and is chiefly a bioterrorism concern (BoNT is a CDC Category A agent).

Clinically actionable points

• Determine the likely causative exposure early: it directs specimen collection (serum for all; stool/enema for colonization forms; wound culture; implicated food) and public-health action.
• Do not feed honey to infants younger than 12 months, but do not exclude infant botulism when honey exposure is absent—most cases are environmental.
• Ask about injection drug use in any adult with an unexplained descending paralysis, even without an obvious wound.
• Counsel that boiling inactivates toxin but not spores; safe home canning requires pressure processing of low-acid foods.

References

Template:WikiDoc Sources